Gut Health Research

Clinical Symptoms Fail to Distinguish Between SIBO and Sucrose Malabsorption A 2026 study from Beth Israel Deaconess Medical Center found that 22% of pa…

Functional gastrointestinal disorders like irritable bowel syndrome and small intestinal bacterial overgrowth confound patients and clinicians

Time-Restricted Eating and Targeted Antibiotics Show Promise for IBS-C Constipation Managing constipation-predominant irritable bowel syndrome (IBS-C) o…

Rifaximin Leads in Efficacy and Safety for IBS-D and SIBO, Systematic Review Finds A comprehensive systematic review of 55 clinical studies shows Rifaxi…

Time-Restricted Eating and Targeted Antibiotics: Two Paths Forward for IBS-C Management A 2026 pilot study from Kristiania University College found that…

Rifaximin Reduces IBS-D Symptoms with Fewer Side Effects Than Other Antibiotics Systematic review evidence from 55 studies shows the antibiotic rifaximi…

A Breath Test for SIBO Found Hydrogen-Positive SIBO in 50% of CIPO Patients In a 2025 study at Niigata University, Japanese gastroenterologists gave a 5…

Half of Japanese Chronic Intestinal Pseudo-Obstruction Patients Showed Hydrogen-Positive SIBO A 2025 study at Niigata University found hydrogen-positive…

Low FODMAP Diet Reduces Bloating Severity by 5 Points in IBS and SIBO Patients A 2026 study from the Medical University of Bialystok examined 98 patient…

90.7% of IBS Patients Reported Symptom Reduction on Low FODMAP Diet A 2026 study from Poland’s Medical University of Bialystok provides fresh evidence o…

For individuals with irritable bowel syndrome with constipation (IBS-C), the search for effective symptom control can be a persistent challenge

For individuals with IBS-C, managing stubborn constipation, bloating, and pain often involves a frustrating cycle of dietary tweaks and medications